Inno.N Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1984)

Organization Overview

First Clinical Trial
2020
NCT04297865
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

HK inno.N Corporation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foot-and-Mouth Disease (Phase 1)

Hand, Foot and Mouth Disease (Phase 1)

Liver Diseases (Phase 1)

Mouth Diseases (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 26